CutisPharma, Inc. - Home

800-461-7449

  • CleanRoom1 web
  • Strategy1 web
  • Production web
  • With better science, higher quality, and reliable consistency,
  • And bold innovation that improves patient care,
  • We are Transforming Medicine.

News & Press Releases

    • July 22, 2016

      CutisPharma CEO Talks to Bloomberg About Compounding Market Hear CEO Neal Muni’s thoughts about changes to the compounding landscape in his interview with Bloomberg.

      READ MORE

    • April 5, 2016

      CutisPharma, Dr. Reddy's Laboratories Announce Partnership Joint development agreement will accelerate NDA filing and worldwide commercialization.

      READ MORE

    • March 2, 2016

      CutisPharma Announces Initiation of Manufacturing Operations Mass. Housing and Economic Development Secretary Jay Ash joins us to commemorate important milestone.

      READ MORE

Information For Customers

  • July, 2016

    Benefits of FIRST®-Vancomycin Presented Stability of antimicrobial activity demonstrated in a scientific abstract presented at the 13th Biennial Congress of the Anaerobe Society of the Americas.

    READ THE ABSTRACT

  • April, 2016

    Superior stability of FIRST®-Vancomycin highlighted in peer-reviewed study. Compared to extemporaneously compounded vancomycin in study published in IJPC.

    READ THE ARTICLE

  •  

    Upcoming 2016 Trade Shows
    NACDS Total Expo

    August 6–9 Boston, MA

    National Pharmacy Purchasing Association

    August 22–25 Las Vegas, NV

  • Jay Ash
  • Emarc
  • MassBio
  • Farewell
  • Sanchez
  • 03.02.16
    Massachusetts Housing and Economic Development Secretary Jay Ash Delivers Keynote Address at CutisPharma Ceremony
    Secretary Ash’s address highlighted CutisPharma’s role in economic growth and job creation in Massachusetts and the close partnership that exists in the Commonwealth between industry, academia, and government. The event to commemorate CutisPharma’s new state-of-the-art manufacturing plant was also attended by MassBio Council CEO Bob Coughlin, Massachusetts College of Pharmacy and Health Sciences President Charles Monahan, Jr. and representatives from the offices of Senate Minority Leader Bruce Tarr and Representative James Miceli.
  • 11.13.15 and 11.20.15
    CutisPharma puts others FIRST!
    CutisPharma stepped out of meetings, put away their lab coats, and rolled up their sleeves to join forces with EMARC. Employees from all departments got together to rake leaves and prepare Fall clean up at multiple locations around the Eastern Middlesex area in Massachusetts.
  • 09.28.15
    MassBio stops by to meet one of their newest members
    Massachusetts Biotechnology Consortium President and CEO Robert Coughlin visited. Joined by Executive VP Sara MacDonald and State Government Relations/Federal and State Policy Consultant John Heffernan, the group enjoyed discussing the new relationship between both organizations as well as a tour of the facility.
  • 05.15
    Patriots Hall of Famer Steve Nelson stops by to say Farewell to founders of CutisPharma after 17 years!
    Former Patriot and football legend Steve Nelson stopped by to wish Dr. Indu and Gita Muni a happy farewell. Indu and Gita founded CutisPharma back in 2000 and moved on to new adventures in May of 2015. While their departure was bittersweet they left behind a wonderful foundation which employees continue to build upon.
  • 03.27.15
    Representative Jeffery Sanchez visits CutisPharma
    State Rep Jeffrey Sánchez, Chairman of the Joint Committee on Health Care Financing visited, joined by Sarah Sabshon, Chief of Staff, and Timothy O’Neill, Research Director for the Committee. During their visit, they met with our Executive team and took a group tour of the facility.

LEADING THE WAY TOWARDS A BETTER SOLUTION

FIRST® KITS address many of the unmet needs in compounding:

Safe alternative to traditional compounding

More convenient for pharmacists to dispense

Predictability in reimbursement claims

READ THE WHITE PAPER

SEE ALL THE KITS



FIRST® KITS - Leading the Way Towards A Better Solution

Connect With Us

Icon TelephoneIcon EMailIcon FacebookIcon TwitterIcon InstagramIcon YouTube